![Haemonetics Corp](/common/images/company/NY_HAE.png)
Haemonetics Corp (HAE)
NYSE
The current HAE market cap is 4.63B. The company's latest EPS is USD 2.3122 and P/E is 39.38.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 304.42M | 311.33M | 318.18M | 336.25M | 343.29M |
Operating Income | 35.26M | 53.66M | 35.3M | 45.98M | 27.94M |
Net Income | 29.38M | 41.04M | 24.91M | 31.24M | 20.37M |
Year End March 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 988.48M | 903.28M | 1B | 1.17B | 1.31B |
Operating Income | 153.95M | 90.78M | 81.33M | 155.65M | 162.88M |
Net Income | 76.53M | 79.47M | 43.38M | 115.4M | 117.56M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.93B | 1.96B | 2.01B | 2.2B | 2.2B |
Total Liabilities | 1.12B | 1.1B | 1.12B | 1.26B | 1.24B |
Total Equity | 818M | 864.62M | 893.66M | 943.32M | 959.96M |
Year End March 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.27B | 1.82B | 1.86B | 1.93B | 2.2B |
Total Liabilities | 680M | 1.09B | 1.11B | 1.12B | 1.24B |
Total Equity | 587.11M | 731.67M | 749.42M | 818M | 959.96M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 273.06M | 19.09M | 118.21M | 117.67M | 181.75M |
Investing | -143.79M | -15.26M | -40.4M | -309.33M | -322.39M |
Financing | -100.36M | -598k | -7.77M | 101.66M | 38.16M |
Year End March 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 158.22M | 108.81M | 172.26M | 273.06M | 181.75M |
Investing | -57.18M | -425.44M | -86.35M | -143.79M | -322.39M |
Financing | -131.21M | 367.45M | -15.75M | -100.36M | 38.16M |
Market Cap | 4.63B |
Price to Earnings Ratio | 39.38 |
Price to Sales Ratio | 3.54 |
Price to Cash Ratio | 25.89 |
Price to Book Ratio | 4.82 |
Dividend Yield | - |
Shares Outstanding | 50.84M |
Average Volume (1 week) | 357.59k |
Average Volume (1 Month) | 446.88k |
52 Week Change | -0.60% |
52 Week High | 97.97 |
52 Week Low | 70.74 |
Spread (Intraday) | 5.6 (6.09%) |
Company Name | Haemonetics Corp |
Address |
155 federal street boston, massachusetts 02110 |
Website | https://www.haemonetics.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.